{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:03:30Z","timestamp":1789499010869,"version":"build-2803163510"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shihwa medical center research fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,26]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Cholangiocarcinoma (CCA) is the second most prevalent primary liver cancer. Microvascular invasion (MVI) indicates more aggressive tumor behavior. While surgery is the primary curative treatment, recurrence, especially in the presence of MVI, remains a considerable concern. This study delves into the impact MVI has on the prognosis of CCA patients after surgical resection. This retrospective study was performed on 177 CCA patients who underwent surgical resection between January 2007 and December 2022. The primary study objective was to determine the impact of MVI on prognosis, especially in early-stage T1 and T2 cases. Clinicopathological findings, including tumor size, differentiation, and metastatic lymph node status, were meticulously analyzed. Of the 177 patients, 104 exhibited MVI (the MVI group), and 73 did not (the nMVI group). The MVI group had a higher incidence of metastatic lymph nodes (45.2% vs 19.2%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.01) and poorer tumor differentiation (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.01). Median disease-free survival (DFS) and overall survival (OS) in the MVI group were notably shorter than in the nMVI group (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.01 for both). In the T1 and T2 subgroups, the presence of MVI was consistently correlated with shorter DFS and OS. Multivariate analysis indicated that the presence of MVI, non-achievement of R0 resection, and higher baseline CA 19-9 levels were associated with poorer OS. This study shows that MVI plays a crucial role by negatively influencing the prognosis of CCA patients because its presence is significantly associated with reduced DFS and OS. These findings emphasize the need for vigilant postoperative monitoring and potential targeted treatments for CCA patients exhibiting MVI.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049292","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:00:45Z","timestamp":1782496845000},"page":"e49292","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The prognostic impact of microvascular invasion in patients with cholangiocarcinoma: A retrospective study"],"prefix":"10.1097","volume":"105","author":[{"given":"Jungnam","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don Haeng","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9911-8823","authenticated-orcid":false,"given":"Jin-Seok","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Shihwa Medical Center, Siheung, South Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma.","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1172\/JCI63212","article-title":"Cholangiocarcinomas can originate from hepatocytes in mice.","volume":"122","author":"Fan","year":"2012","journal-title":"J Clin Invest"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"E3806","DOI":"10.1073\/pnas.1619416114","article-title":"Biliary epithelial injury-induced regenerative response by IL-33 promotes cholangiocarcinogenesis from peribiliary glands.","volume":"114","author":"Nakagawa","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma.","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"158","DOI":"10.32074\/1591-951X-252","article-title":"Cholangiocarcinoma.","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management.","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.ejso.2019.04.019","article-title":"The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.","volume":"45","author":"Lurje","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.hpb.2019.07.003","article-title":"Left-versus right-sided hepatectomy with hilar en-bloc resection in perihilar cholangiocarcinoma.","volume":"22","author":"Bednarsch","year":"2020","journal-title":"HPB (Oxford)"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1245\/s10434-019-08192-z","article-title":"ALPPS for locally advanced intrahepatic cholangiocarcinoma: did aggressive surgery lead to the oncological benefit? An international multi-center study.","volume":"27","author":"Li","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.ejso.2019.05.025","article-title":"Does lymphovascular invasion really associate with decreased overall survival for patients with resected cholangiocarcinoma?","volume":"45","author":"Ma","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.gastro.2009.06.003","article-title":"A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma.","volume":"137","author":"Roayaie","year":"2009","journal-title":"Gastroenterology"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0168-8278(02)00360-4","article-title":"Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.","volume":"38","author":"Imamura","year":"2003","journal-title":"J Hepatol"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1245\/s10434-019-07227-9","article-title":"Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma.","volume":"26","author":"Erstad","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00000478-200201000-00003","article-title":"Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index.","volume":"26","author":"Lauwers","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R17-20260915","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.hpb.2019.02.003","article-title":"Effect of microvascular invasion on the postoperative long-term prognosis of solitary small HCC: a systematic review and meta-analysis.","volume":"21","author":"Chen","year":"2019","journal-title":"HPB (Oxford)"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-017-3050-x","article-title":"Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B.","volume":"17","author":"Huang","year":"2017","journal-title":"BMC cancer"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1245\/s10434-012-2739-y","article-title":"Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors.","volume":"20","author":"Shindoh","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1245\/s10434-011-2195-0","article-title":"Predictors for microinvasion of small hepatocellular carcinoma \u2264 2 cm.","volume":"19","author":"Yamashita","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.25832","article-title":"Resection of hepatocellular cancer \u2264 2 cm: results from two Western centers.","volume":"57","author":"Roayaie","year":"2013","journal-title":"Hepatology"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jhep.2015.10.015","article-title":"Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specific survival of patients with hepatocellular carcinoma.","volume":"64","author":"Shindoh","year":"2016","journal-title":"J Hepatol"},{"key":"R23-20260915","first-page":"1170","article-title":"Roles and molecular mechanisms of biomarkers in hepatocellular carcinoma with microvascular invasion: a review.","volume":"11","author":"Zhao","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease.","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial\u2013mesenchymal transition.","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrm1835","article-title":"Complex networks orchestrate epithelial\u2013mesenchymal transitions.","volume":"7","author":"Thiery","year":"2006","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.3390\/cancers12113370","article-title":"Biliary tract cancers: molecular heterogeneity and new treatment options.","volume":"12","author":"Personeni","year":"2020","journal-title":"Cancers (Basel)"},{"key":"R28-20260915","first-page":"122","article-title":"Vascular-endothelial response to IDH1 mutant fibrosarcoma secretome and metabolite: implications on cancer microenvironment.","volume":"9","author":"Mao","year":"2019","journal-title":"Am J Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:09:26Z","timestamp":1789495766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":27,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049292","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2024-02-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}